TABLE 1

Characteristics of subjects according to lung function categories and smoking history

Subjects with normal spirometrySubjects with PRISmSubjects with airflow limitation
Never-smokerSmokerNever-smokerSmokerNever-smokerSmoker
Subjects914516868746169
Age (years)57.7±10.457.2±10.762.4±10.363.5±10.866.4±11.068.1±9.6
Male358 (39.2)450 (87.2)*33 (38.4)76 (87.4)*24 (52.2)150 (88.8)*
BMI (kg·m−2)23.1±3.824.0±3.3*24.2±4.624.6±3.724.1±3.223.4±3.8
Smoking status, current0 (0)366 (70.9)*0 (0)57 (65.5)*0 (0)83 (49.1)*
Smoking duration, ≥20 pack-years0 (0)307 (59.5)*0 (0)72 (82.8)*0 (0)147 (87.0)*
FVC (% pred)97.6±11.796.8±10.874.4±8.773.6±8.492.8±17.684.8±18.7*
FEV1 (% pred)99.7±11.697.2±10.6*73.1±7.371.8±7.476.5±16.466.3±20.1*
FEV1/FVC0.81±0.050.79±0.05*0.78±0.050.77±0.050.64±0.060.60±0.09*
TLCCT (% pred)86.9±12.385.1±11.7*74.7±12.375.5±13.490.1±13.391.3±14.0
FVC/TLCCT (%)70.4±10.671.3±9.761.4±10.560.3±13.161.3±11.955.7±15.0*
Prevalence of PSE23 (2.5)187 (36.2)#1 (1.2)38 (43.7)#2 (4.3)120 (71.0)#
Prevalence of CLE17 (1.9)164 (31.8)#4 (4.7)40 (46.0)#5 (10.9)134 (79.3)#

Data are presented as n, mean±sd or n (%). PRISm: preserved ratio impaired spirometry; BMI: body mass index; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; TLCCT: total lung capacity measured by computed tomography; PSE: paraseptal emphysema; CLE: centrilobular emphysema. *: statistically significant (p<0.05) compared to never-smokers within the same lung function category; #: statistically significant (adjusted p<0.05, adjusted by Bonferroni method) compared to never-smokers within the same lung function category. The adjusted p-values comparing PRISm and other lung function categories in smokers were as follows. PSE: versus normal spirometry p=1.00, versus airflow limitation p<0.01; CLE: versus normal spirometry p=0.21, versus airflow limitation p<0.01.